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Head and neck — 
cancer project yields 
encouraging results 
in prevention 
The Humphrey Cancer Research Center 
has long been known for work on 
understanding the basic mechanisms of 
cancer. Now, research being led by 
l^enter member Marianne Prout, M.D., 
an associate professor of public health, is 
opening up the evolving field of 
cancer-prevention research, or how to 
apply what is known about cancer so that 
the disease can be avoided. 
' 'Applying what we know is a whole 
area of research that has been ignored, 
but it is really important," says Dr. Prout. 
Two years ago, the National Cancer 
Institute (NCI) announced that 50 
percent of all cancer deaths could be 
avoided by the year 2000 and selected 
Dr. Prout to set up one of three 
demonstration projects in the country to 
show how this might be accomplished. 
Armed with the five-year NCI grant. 
Dr. Prout, a former chief of medical 
oncology at Boston City Hospital, and 
faculty from Boston University School 
of Public Health have created a model 
program using Boston's primary 
health-care network for the early 
detection and prevention of head and 
neck cancer. The demonstration project 
is timely in light of a four-year study of 
cancer rates in Massachusetts that 
revealed levels of head and neck cancer 
in Suffolk county, which includes 
Boston, to be about twice the national 
average. Dr. Prout, who directed the 
research on the Boston cases, attributes 
this to a higher incidence of smoking and 
continued on page 2 
Marianne Prout, M.D., center, demonstrates head and neck cancer screening techniques to third-
and fourth-year students at Boston University School of Medicine. (Photo by Gustav Freedman) 
Humphrey Cancer Center member moves 
closer to the truth about vitamin A and cancer 
As much as 35 percent of cancer is 
related to diet, studies show. Eating less 
fat and more fiber-containing foods, such 
as whole grain breads, fresh fruits and 
vegetables, can reduce your cancer 
risk—but how? 
To answer a part of this question, 
Humphrey Cancer Research Center 
member Richard Niles, Ph.D., is 
investigating the anti-tumor effects of 
one important dietary requirement— 
vitamin A. 
Dr. Niles and his colleagues have a 
number of experiments under way aimed 
at revealing how retinoic acid, the form 
vitamin A is converted to in the body, 
inhibits tumor growth and prompts a 
tumor's undifferentiated cells to retum to 
their normal functioning state. 
All the different cells that make up the 
body—hair, skin, bone, nerves, intemal 
organs, for example—originate from a 
few basic cell types during development 
in the womb. The process by which cells 
gain the specific characteristics that 
enable them to carry out the 
responsibilities of a liver cell or a lung 
cell is called differentiation. Tumors are 
like a reversion to the ancestral 
state—undifferentiated and consequently 
not functioning properly. 
A critical amount of vitamin A, then, 
is required for normal cell development. 
It also maintains cells, specifically 
epithelial cells, in their normal state of 
differentiation and, hence, normal 
functioning, explains Dr. Niles, who also 
is a professor of biochemistry at Boston 
University School of Medicine. Epithe-
lial cells are those that line body cavities 
and carry out most of the functions of 
continued on page 2 
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Vitamin A 
continued from page 1 
various organs. 
Vitamin A, which we get by eating 
such vegetables as tomatoes, carrots and 
red peppers, keeps these cells in their 
proper state so that they can do their job. 
To understand how vitamin A works 
against tumors. Dr. Niles is looking at 
three cell-culture systems: 
• In a melanoma cell line, he is inves-
tigating how retinoic acid inhibits cell 
growth and changes the activity of two 
key regulatory enzymes involved in 
growth and differentiation. 
• In a teratocarcinoma cell line derived 
from mouse testes, he is observing how 
retinoic acid plus another vital cell 
chemical transform the malignant cells 
into non-malignant cells that do not 
cause tumors when injected back into the 
mouse. 
• A third set of experiments involves 
normal cells derived from the respiratory 
tract of a hamster. When these epithelial 
Richard Niles, Ph.D., discusses his vitamin A 
research. (Photo by Michael McGovern) 
cells (the "hairy" and mucus-producing 
cells of the airway) are cultured, they 
tend to lose their differentiated 
characteristics and grow rapidly until 
they fill the culture dish. At that point, 
the cells reacquire their normal character. 
If retinoic acid is added at a time when 
the cells are rapidly growing (i.e., 
without differentiation), differentiation 
can largely be preserved. 
"This is important," says Dr. Niles, 
"because if you put animals on a vitamin 
A-deficient diet, you can observe the 
cells of the windpipe flatten out and lose 
their differentiated properties, which is 
characteristic of a pre-cancerous change. 
You can remove these cells from the 
animal and culture them with vitamin A 
and restore their normal shape and 
function." 
Dr. Niles also is developing a model 
to study carcinogenesis in normal 
epithelial cells. "About 75 percent of 
human cancers are derived from 
epithelial cells. Cancers of the breast, 
colon, prostate and lung all are epithelial 
in origin," he says. 
Cancer Prevention 
continued from page 1 
drinking in the metropolitan area than in 
other areas of the Commonwealth. Other 
possible contributing factors are air 
pollution, exposure to asbestos and poor 
vitamin nutrition, she says. 
Although head and neck cancer 
carries a high mortality rate, these deaths 
can be significantly reduced if people at 
risk can be identified and screened early. 
Dr. Prout has established a city wide 
program to find out where patients who 
have advanced head and neck cancer 
have previously sought health care and to 
place early detection programs in those 
locations. 
' 'We are trying to figure out where 
people already are going for their 
primary health-care needs and to place 
screening programs in those locations," 
says Dr. Prout. 
"Essentially, we're trying to make 
early detection a part of people's routine 
health care ." 
This type of front-line approach 
requires that primary health-care 
physicians, nurses and staff be educated 
about who is most at risk for developing 
head and neck cancer—^primarily people 
over the age of 40 who smoke and drink 
alcohol—and that they be given the skills 
necessary to do the screening directly at 
the clinic. Dr. Prout works closely with 
the staff to streamline the system so that 
follow-up is easy both for patients and 
health-care providers. 
" W e ' r e troubleshooters," she 
explains. ' 'We try to solve problems in a 
practical way—such as having joint 
luncheons to get staff from one area 
talking to staff from another, and having 
fixed appointment slots available for 
patients referred because of head and 
neck cancer screening so that it is easy 
for both staff and patients to make the 
next appointment. ' ' 
The cornerstone of the demonstration 
—project is the effic4enUand-effective use -
of medical resources. "Obviously we 
can't screen everybody all the time for 
everything. Instead, we need to make 
sure that the providers parcel out their 
time and medical resources where they 
will do the most good," says Dr. Prout. 
"Eor example, we believe people who 
are most at risk for developing head and 
neck cancer are not being identified as 
well as they might be. Our providers are 
very careful about screening those 
patients who have been identified as 
smokers, but they only ask about half the 
people seen whether they smoke. At the 
same time, about two-thirds of non-
smokers are being screened and it 's 
possible that this is an inefficient use of 
time and resources. What we're working 
on is how to get the right service to the 
right people quickly." 
Two years into the five-year project. 
Dr. Prout is enthusiastic about what she 
has seen in the neighborhood health 
centers in Boston. Her efforts to get 
early detection programs in place where 
they will do the most good are eagerly 
met by professionals who, she says, are 
' 'tremendously idealistic. ' ' 
"These health-care providers want to 
do whatever they can to help patients. 
Most have seen the effects of advanced 
head and neck cancer and want to help 
patients avoid i t , " says Dr. Prout. 
Already during the first year of limited 
out-patient screening at one location, five 
early cancers have been detected. " F o e 
health-care providers who have seen the 
effects of radical therapy all of a sudden 
to see five people who can avoid this 
trauma is incredibly reinforcing," she 
says. 
While Dr. Prout is showing that much 
can be accomplished through the city's 
existing health-care system, she is using 
another grant from NCI to develop 
courses for Boston University School of 
Medicine and School of Public Health 
students and faculty to look at cancer 
prevention in its entirety. 
Dr. Prout hopes that cancer 
prevention measures eventually will be 
incorporated into routine health care, as 
has been done with heart disease. Ideally 
she wants everyone to hear the same 
message from their primary health-care 
provider: ' 'Most cancer can be avoided 
and here's what you can do to prevent 
i t ." 
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Humphrey Center researcher seeks 
to build better monoclonal antibodies 
Under normal conditons, the human 
body can defend itself magnificently 
against the majority of diseases with the 
help of molecules called antibodies. 
Antibodies are specialized proteins 
produced as needed by certain cells to 
neutralize what the body views as 
"hos t i l e " foreign elements—called 
antigens—whether they stem from a 
common infection or from the emer-
gence of a tumor. 
Sometimes, however, the body may 
not be able to raise its army of antibodies 
against a particular antigen, either 
because the immune system already is 
overtaxed or because the foreign invader 
somehow eludes the defense, as in the 
case of acquired immune deficiency 
syndrome (AIDS) or cancer. Even under 
normal conditions, not all antibodies 
attack and bind to antigens with 
100-percent efficiency. 
For this reason, monoclonal anti-
bodies, which are derived from natural 
antibodies obtained from a mouse or rat, 
represent one of the most hopeful 
^ - - v developments in the treatment of disease, 
: especially cancer. As specially designed 
"magic bul le ts" that can seek out and 
bind to a specific target with great 
efficiency, monoclonal antibodies are 
being experimented with in both the 
diagnosis and treatment of various 
cancers. Yet, because no one fully 
understands what happens between 
antibodies and antigens at the molecular 
level, there is room for improvement in 
the design of new monoclonal antibodies. 
Since joining the Humphrey Cancer 
Research Center in 1985, Jacqueline 
Sharon, Ph.D., an assistant professor of 
pathology at Boston University School 
of Medicine, has been working on the 
problem of how to build a better 
monoclonal antibody. The clinical 
applications of her work may someday 
include the eradication of tumors and 
control of the rejection of transplanted 
organs. 
Produced in cultures in the laboratory, 
monoclonal antibodies are a pure strain 
of highly specific antibodies that react 
strongly and specifically with a 
particular antigen. But because r monoclonal antibodies are made by first raising the antibody of choice in a mouse 
and then fusing it with a tumor cell to 
produce a clone, there is a problem with 
rejection when the new antibody is 
introduced into another species, such as a 
human. 
To understand more about the fine 
details of the interactions between anti-
bodies and antigens. Dr. Sharon 
introduces mutations into the gene 
responsible for producing an antibody 
and observes how the change affects the 
antibody's structure and, therefore, its 
ability to bind to the target antigen. She 
uses a laboratory technique that allows 
her to direct whatever changes she wants 
by making specific changes in the 
chemical composition of the gene. 
Dr. Sharon then measures the strength 
of the interaction between the antibody 
and the antigen. Her hope is to find out 
if there are certain positions in the anti-
body sequence that are especially 
important to its binding ability. If so, it 
may be possible to manufacture an 
antibody with only those changes crucial 
to its most effective functioning, and 
then only this small active portion can be 
grafted onto the constant region of a 
human antibody molecule to minimize 
the possibility of rejection. (In all 
antibodies, it appears, there is a variable 
or active region that actually binds to an 
antigen, and a constant region that is not 
directly involved.) 
In her current studies. Dr. Sharon is 
looking at two antibodies that bind to the 
same antigen, but one has a binding 
efficiency 200 times greater than the 
other. A comparison of the antibodies' 
amino acid sequences has revealed eight 
differences in one area of the molecules. 
What Dr. Sharon wants to know is how 
many of these differences contribute to 
the stronger interaction. Possibly, she 
says, some differences are deleterious 
mutations, that is, they actually 
contribute to a lowering of the binding 
efficiency. However, it also is possible 
that some combination of changes in one 
antibody would yield an even higher 
binding efficiency but because of another 
mutation, this ability is kept to a lower 
level. 
" W e are investigating how many of 
these differences actually contribute to a 
higher binding efficiency by sequentially 
turning the sequence of antibody x into 
antibody y. At each stage we are 
looking at what is the effect of changing 
a particular amino acid ," says Dr. 
Sharon. 
Dr. Sharon is working with an 
experimental mouse- and rat-model 
system and is looking at the surface 
antigen on T-lymphocytes, a principal 
type of infection-fighting cell responsible 
for producing various types of antibodies. 
Jacqueline Sharon, Ph.D., at work in her 
laboratory. (Photo by Gustav Freedman) 
QUESTIONS... 
Answer to question on page 3. 
The question of whether 
non-smokers who must breathe the 
smoke of others' cigarettes incur a 
greater risk of lung cancer is of 
increasing controversy as cities and 
institutions struggle with the issue of 
banning smoking in public places. 
Several scientific studies, including a 
recent study by the American Cancer 
Society, have found an increased risk of 
lung cancer among nonsmoking wives of 
cigarette smokers. Although not all 
sudies have shown an effect, growing 
evidence indicates that "second-hand 
smoke" is a health hazard. Major 
reports by the National Academy of 
Sciences and the Surgeon General state 
that involuntary smoking is a problem, 
and a 1986 NAS report stated that the 
amount of smoke inhaled on airplane 
trips constitutes a hazard and 
recommended that cigarette smoking on 
airplanes be banned. 
An American Cancer Society 
Prevention study, currently under way 
involving more than one million 
Americans, will include a careful 
assessment of cancer risk among 
smokers and involuntary smokers. 
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CANCER NOTES 
CANCER NOTE: For the average-risk 
woman, a Pap test for the detection of 
cervical cancer is recommended once 
every three years, although some 
physicians may recommend continuing 
annual check-ups. The Pap test is highly 
effective in detecting cancer of the 
cervix, but less effective in detecting 
uterine cancer. 
CANCER NOTE: With summertime 
approaching, now is a good time to 
remind people of the dangers of 
unprotected exposure to too much direct 
sunlight. Skin cancer can be 
successfully treated if it is detected early. 
Melanomas often start as small, molelike 
growths that increase in size, change 
color, and bleed easily from a slight 
injury. This simple ABCD rule will help 
individuals remember the warning signs 
of melanoma: A is for asymmetry—one 
half of the mole does not match the 
other. B is for border irregularity— 
edges are ragged or blurred. C is for 
color—the color of the mole is not 
uniform. D is for diameter—any sudden 
or continuing increase in size should be 
checked by a physician. 
The Humphrey Cancer Center News is 
published for the Hubert H. Humphrey 
Cancer Research Center of Boston 
University School of Medicine by the 
Office of Publication Services, Boston 
University Medical Center. Humphrey 
Center Director, Herbert H. Wotiz, 
Ph.D.; Editor, Denise Maguire; Writer, 
Caroline H. Lupfer. ' ' Cancer Notes ' ' 
information is provided courtesy of the 
American Cancer Society. 
What are the risks associated 
with 'second-hand smoke'? 
ANSWER ON PAGE 3 
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